CD209 and COVID-19: In the context of the recent SARS-CoV-2 pandemic, involvement of DC-SIGN has been linked to severe cases of COVID-19 (Thépaut et al., 2021), possibly competing with neutralizing antibodies to the RBD-motif (Lempp et al., 2021).